This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
2Find
3Review
4Get in touch
More info
You can access this
clinical trial
if you have
Hepatitis B, Poliomyelitis, Diphtheria, Acellular Pertussis, Tetanus or Haemophilus Influenzae Type b
and you are
between 8 and 15
years old
4
The primary goal of this phase is to monitor the long-term effects.
The treatment is already on the market.
Show me locations

The purpose

The study will compare the immunogenicity and the reactogenicity of INFANRIX™ HEXA and HEXAVAC™ vaccines in a 3, 5 and 11 - 12 month vaccination schedule.

Provided treatments

  • Biological: DTPa-HBV-IPV/Hib Vaccine (INFANRIX™ HEXA)
  • Biological: DTPa-HBV-IPV-Hib vaccine (HEXAVAC™)

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01457547. The sponsor of the trial is GlaxoSmithKline and it is looking for 494 volunteers for the current phase.
Official trial title:
Study to Assess and Compare the Immunogenicity and Reactogenicity of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (INFANRIX™ HEXA) and Aventis Pasteur MSD's DTPa-HBV-IPV-Hib Vaccine (HEXAVAC™) Given at 3, 5 and 11-12 Months of Age